Evidence map›Paper›PMID 35154158›Full record

Observational studyFrontiers in immunology2022

Association Between Sex Hormone Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study.

Anna Beltrame, Pedro Salguero, Emanuela Rossi, Ana Conesa, Lucia Moro, Laura Rachele Bettini, Eleonora Rizzi, Mariella D'Angió, Michela Deiana, Chiara Piubelli and 6 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Anna BeltrameDepartment of Infectious, Tropical Diseases and Microbiology Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S). Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.
Pedro SalgueroDepartment of Applied Statistics, Operations Research and Quality, Universitat Politècnica de València, Valencia, Spain.
Emanuela RossiBicocca Center of Bioinformatics, Biostatistics and Bioimaging, School of Medicine and Surgery, Milano-Bicocca University, Milano, Italy.
Ana ConesaInstitute for Integrative Systems Biology, Spanish National Research Council, Paterna, Spain.
Lucia MoroDepartment of Infectious, Tropical Diseases and Microbiology Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S). Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.
Laura Rachele BettiniPediatric Departement and Centro Tettamanti-European Reference Network PaedCan, EuroBloodNet, MetabERN-University of Milano-Bicocca-Fondazione MONZA e BRIANZA per il BAMBINO e la sua MAMMA (MBBM)-Ospedale, San Gerardo, Monza, Italy.
Eleonora RizziDepartment of Infectious, Tropical Diseases and Microbiology Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S). Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.
Mariella D'AngióPediatric Departement and Centro Tettamanti-European Reference Network PaedCan, EuroBloodNet, MetabERN-University of Milano-Bicocca-Fondazione MONZA e BRIANZA per il BAMBINO e la sua MAMMA (MBBM)-Ospedale, San Gerardo, Monza, Italy.
Michela DeianaDepartment of Infectious, Tropical Diseases and Microbiology Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S). Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.
Chiara PiubelliDepartment of Infectious, Tropical Diseases and Microbiology Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S). Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.
Paola ReboraBicocca Center of Bioinformatics, Biostatistics and Bioimaging, School of Medicine and Surgery, Milano-Bicocca University, Milano, Italy.
Silvia DurantiDepartment of Infectious, Tropical Diseases and Microbiology Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S). Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.
Paolo BonfantiSchool of Medicine and Surgery, Milano-Bicocca University, Milano, Italy.
Ilaria CapuaOne Health Center of Excellence, University of Florida, Gainesville, FL, United States.
Sonia TarazonaDepartment of Applied Statistics, Operations Research and Quality, Universitat Politècnica de València, Valencia, Spain.
Maria Grazia ValsecchiBicocca Center of Bioinformatics, Biostatistics and Bioimaging, School of Medicine and Surgery, Milano-Bicocca University, Milano, Italy.
University of Milano-Bicocca · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITOspedale Sacro Cuore Don Calabria · ITUniversitat Politècnica de València · ESUniversity of Florida · USUniversity of Florida Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the cause of sex disparities in COVID-19 outcomes is a major challenge. We investigate sex hormone levels and their association with outcomes in COVID-19 patients, stratified by sex and age. This observational, retrospective, cohort study included 138 patients aged 18 years or older with COVID-19, hospitalized in Italy between February 1 and May 30, 2020. The association between sex hormones (testosterone, estradiol, progesterone, dehydroepiandrosterone) and outcomes (ARDS, severe COVID-19, in-hospital mortality) was explored in 120 patients aged 50 years and over. STROBE checklist was followed. The median age was 73.5 years [IQR 61, 82]; 55.8% were male. In older males, testosterone was lower if ARDS and severe COVID-19 were reported than if not (3.6

Indexed as

Sex CharacteristicsAgedAged, 80 and overCohort StudiesCOVID-19FemaleGonadal Steroid HormonesHospitalizationHospital MortalityHumansItalyMaleMiddle AgedRetrospective StudiesRisk FactorsSARS-CoV-2Gonadal Steroid HormonesARDSCOVID-19estradioloutcomeseveritysex hormonestestosterone

Identifiers

PMID35154158
PMCPMC8829540
OpenAlexW4210449595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.